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ABSTRACT
Several different approaches exist to generate ex-
pressed RNA interference (RNAi) precursors for
multiple target inhibition, a strategy referred to as
combinatorial (co)RNAi. One such approach makes
use of RNA Pol III-expressed long hairpin RNAs
(lhRNAs), which are processed by Dicer to
generate multiple unique short interfering siRNA ef-
fectors. However, because of inefficient intracellular
Dicer processing, lhRNA duplexes have been limited
to generating two independent effective siRNA
species. In this study, we describe a novel strategy
whereby four separate anti-HIV siRNAs were
generated from a single RNA Pol III-expressed tran-
script. Two optimized lhRNAs, each comprising two
active anti-HIV siRNAs, were placed in tandem to
form a double long hairpin (dlhRNA) expression
cassette, which encodes four unique and effective
siRNA sequences. Processing of the 30 position
lhRNA was more variable but effective multiple pro-
cessing was possible by manipulating the order of
the siRNA-encoding sequences. Importantly, unlike
shRNAs, Pol III-expressed dlhRNAs did not compete
with endogenous and exogenous microRNAs to
disrupt the RNAi pathway. The versatility of ex-
pressed lhRNAs is greatly expanded and we
provide a mechanism for generating transcripts
with modular lhRNAs motifs that contribute to
improved coRNAi.
INTRODUCTION
Exogenous RNA intermediates of the RNA interference
(RNAi) pathway have become powerful tools for the de-
velopment of reverse genetics approaches and novel thera-
peutics against a wide variety of diseases (1). Speciﬁcally,
expressed short hairpin RNAs (shRNAs), which mimic
precursor microRNA (pre-miRNA), are Dicer substrates
of the mammalian miRNA pathway and have been exten-
sively exploited for the production of eﬀectors of the
RNAi pathway (2). However, to prevent emergence of
resistant viral mutants from highly mutable targets, such
as those of human immunodeﬁciency virus (HIV) and
hepatitis C virus (HCV), a combination of multiple
short interfering RNA (siRNA) eﬀectors is required
(3,4). Therefore, an eﬀective combinatorial RNAi
(coRNAi) system aimed at generating active siRNA
products, and which is capable of targeting multiple sites
simultaneously, remains an important objective.
Harnessing the RNAi pathway to suppress multiple
gene targets concurrently has been attempted using
several diﬀerent coRNAi strategies with varying success.
The most common approach is to place shRNA expres-
sion cassettes adjacent to each other to achieve combined
expression of multiple shRNAs (5–9). However, there are
several limitations to combining multiple shRNA cas-
settes. Typically shRNAs are expressed from powerful
constitutively active promoters (e.g. U6, H1 and U1 pro-
moters). A coRNAi approach, with several shRNA ex-
pression cassettes in tandem, risks overwhelming the
endogenous RNAi pathway. High levels of speciﬁc
shRNAs may have serious and potentially fatal conse-
quences, which are important for application to gene
therapy (10). Another concern relates to the use of
lentiviral vectors, which are often employed to deliver
therapeutic anti-HIV RNAi sequences to T cells. These
vectors are prone to recombining or deleting repeat se-
quences (11,12). Although this problem may be alleviated
by simultaneous use of diﬀerent promoters (8), such an
arrangement of expressed silencing sequences would
require careful empirical assessment to optimize expres-
sion of each shRNA. Other coRNAi approaches have
made use of a combination of primary microRNA
(pri-miRNA) shuttles, where siRNA guide sequences are
placed within mimics of endogenous polycistronic
pri-miRNAs (13–18). Although polycistronic pri-miRNA
shuttles represent a promising coRNAi approach, eﬃcient
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precursors is variable (13,15,18) and development of new
methods of achieving coRNAi remains important.
Exploiting the action of endogenous Dicer to process
long dsRNA templates and form multiple siRNA species
is potentially a useful approach for achieving coRNAi.
The most well-studied method is to employ Pol III pro-
moters to generate transcripts with deﬁned 50- and
30-termini that fold into long hairpins with duplex
regions of between 30 and 100bp (19–27). These
lhRNAs, which have 2nt 30-OH overhangs have been
shown to be intracellular Dicer substrates and produce
multiple siRNA species (19–23). We and others have
shown that siRNAs are processed by Dicer in a gradient
of decreasing eﬃciency, which starts from the base of the
dsRNA hairpin duplex and moves towards the apical loop
(19,20,22,26).
Here we describe a novel lhRNA-based strategy
whereby four independent siRNAs were produced in ef-
fective doses from a single RNA Pol III-expressed tran-
script. Two optimized dual-targeting lhRNAs were placed
in tandem within a single transcript to form a double long
hairpin RNA (dlhRNA) template. We show that the
dlhRNA is processed into two lhRNAs, which in turn
produce four active anti-HIV siRNAs. Moreover, there
was no evidence of disruption of the endogenous
miRNA pathway by dlhRNAs. This work describes a
novel and safe dlhRNA approach to coRNAi and
expands the versatility of expressed lhRNAs for applica-
tions requiring simultaneous silencing of multiple targets.
MATERIALS AND METHODS
Hairpin expression plasmids
The procedure for generating hairpin RNAs is a modiﬁ-
cation of the PCR-based method described by Castanotto
et al. (28) and later adapted by ourselves to generate
lhRNAs (20). A panel of twelve U6-driven lhRNAs
encoding two putative siRNA sequences targeted to the
HIV-1 tat and nef or int and LTR sequences was con-
structed using two rounds of PCR. Selection of target
sites was based on previously reported eﬀective
knockdown of HIV-1 tat (29), nef (23), int (30) and LTR
(20) sequences by shRNAs. Oligonucleotide sequences
used in each of the ampliﬁcation reactions are provided
in Supplementary Table 1. During the ﬁrst round of PCR
a U6 promoter-containing plasmid DNA, pTZ-U6+1, was
used as template (31). A universal U6 forward primer
complementary to the 50-end of the U6 promoter was
used for both rounds of PCR. The reverse primers for
the ﬁrst round of PCR were complementary to 18–21nt
of the 30-end of the U6 promoter and included sequences
encoding the sense strand and loop of the lhRNA. The
ﬁrst round of PCR product was used as template for the
second round of PCR. The round two reverse primer se-
quences were designed to hybridize to the loop-encoding
region at the 30 extremity of the ﬁrst round PCR amplicon.
These primers included the sequence encoding the anti-
sense strand of the lhRNA as well as a RNA Pol III ter-
mination signal. Double-lhRNA expression cassettes were
similarly generated using the two-round PCR method
described above, but previously generated lhRNAs were
used as templates. For dlhRNAs, round one reverse
primers were complementary to the last 18nt of the
lhRNA template that would be positioned at the 50-side.
These primers included a spacer of two adenosine residues
and a sequence encoding the sense strand of the
30-lhRNA. To complete synthesis of the dlhRNA cas-
settes, round two reverse primers were employed that
were the same as those used during the second round of
PCR to generate lhRNA cassettes. To propagate the ex-
pression cassettes, the ﬁnal PCR products were ligated
directly to the TA cloning vector pTZ57R/T (Fermentas,
WI, USA), and sequences were conﬁrmed using standard
procedures. Twelve lhRNA plasmids were generated:
plhLTR-int +1, plhLTR-int +2, plhLTR-int +3,
plhint-LTR+1, plhint-LTR+2, plhint-LTR+3, plhtat-nef
+1, plhtat-nef+2, plhtat-nef+3, plhnef-tat+1, plhnef-tat
+2 and plhnef-tat +3. Two dlhRNA plasmids were
propagated: plhLI-TN and plhTN-LI. U6-driven
shRNAs encoding siRNAs corresponding to those
included in the lhRNA expression constructs were
generated using a single round of PCR. The U6
promoter-containing plasmid DNA was used as
template. Ampliﬁcation with the universal U6 forward
primer and speciﬁc reverse primers enabled formation of
the shRNA-encoding sequences and these were inserted
into pTZ57R/T (Fermentas) to generate: pshLTR,
pshint, pshtat and pshnef. pH1-lhtat-nef +1 and
p7SK-lhLTR-int +1 are plasmids expressing two
lhRNAs from H1 and 7SK promoters, respectively.
These transcriptional regulatory elements were
incorporated using a similar procedure to that described
above, but genomic DNA from HEK293 cells was used as
a template. Forward and reverse primers used during the
ﬁrst round of PCR are listed in Supplementary Table 1.
Second round reverse primers were the same as those used
to generate U6-driven lhRNAs.
Target plasmids
Dual luciferase sense and antisense target plasmids were
constructed by inserting annealed oligonucleotides
encoding the HIV-1 targets into the 30-UTR of the
Renilla Luciferase cassette of the psiCheck-2 plasmid
(Promega, WI, USA). After treatment with polynucleotide
kinase (Promega) sticky end-containing duplex oligo-
nucleotides were ligated to XhoI–NotI sites (sense
targets) or XhoI–SpeI sites (antisense targets). Sequences
of these oligonucleotides are provided in Supplementary
Table 2. Identiﬁcation of correct clones was facilitated by
the introduction of an EcoRV site within each insert.
Cell culture and transfections
HEK293 and Huh7 cells were maintained in Dulbecco’s
modiﬁed Eagle’s medium (DMEM; BioWhittaker, MD,
USA) supplemented with 10% heat inactivated fetal calf
serum (FCS; Delta Bioproducts, Johannesburg, South
Africa) at 37 C and 5% CO2. U87.CD4.CCR5 cells were
maintained in DMEM supplemented with 15% FCS,
1mg/ml puromycin, 300mg/ml G418, glutamine, penicillin
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ratio of 1ml Lipofectamine2000 (Invitrogen, CA, USA) to
1mg total DNA according to the manufacturer’s instruc-
tions. Medium was changed 24h after transfection and
analyses were carried out a further 24h thereafter.
Co-transfecting a plasmid that constitutively produces
enhanced green ﬂuorescent protein (pCI-eGFP) followed
by ﬂuorescence microscopy was used to verify equivalent
transfection eﬃciencies (32).
To evaluate the eﬀects of the lhRNA- and shRNA-
encoding plasmids on a reporter target, 120000
HEK293 cells were seeded 24h prior to transfection in
each well of a 24-well culture dish. Cells were transfected
with 150ng target plasmid, 750ng of lhRNA or shRNA
encoding plasmid and 100ng of pCI-eGFP, unless other-
wise stated. For northern blot analysis HEK293 cells were
seeded at 80% conﬂuency in 10-cm culture dishes 24h
prior to transfection. Cells were transfected with 18mgo f
hairpin-encoding plasmid and 1mg pCI-eGFP. To deter-
mine the induction of interferon (IFN) response-related
genes, HEK293 cells were seeded as described above and
transfected with 900ng of lhRNA or shRNA encoding
plasmid and 100ng pCI-eGFP per well. Control
double-stranded RNA, Poly (I:C; Sigma, MO, USA),
was transfected at equivalent amounts to the hairpin
encoding plasmids. Measurement of IFN response
gene mRNA concentrations were then determined using
quantitative PCR according to previously described
methods (33).
To assess saturation of the endogenous miRNA
pathway caused by the lhRNA constructs, Huh7 cells
were co-transfected with 80ng psiCheck-miR-16T 7
(18), 750ng hairpin expression plasmid or
pTZ-U6-miR-16S 7 sponge and 150ng pCI-eGFP.
psiCheck-miR-16T 7 is a psiCheck plasmid-containing
7 miR-16 target sites downstream of the Renilla luciferase
ORF and pTZ-U6-miR-16S 7 sponge includes a Pol III
expression cassette that transcribes RNA containing seven
copies of a miR-16 target site. To determine the eﬀects of
the lhRNA constructs on the silencing eﬃcacy of an ex-
ogenous miRNA, HEK293 cells were cotransfected with
100ng pCMV miR-31 HBx, 100ng of psiCheck-HBx
together with the hairpin constructs (18,34). pCMV
miR-31 HBx encodes a miRNA shuttle that has a guide
cognate in the X gene (HBx) of hepatitis B virus, and
psiCheck-HBx is the reporter target vector.
Dual luciferase reporter assay
Fireﬂy and Renilla luciferase activity was determined
using a Veritas dual-injection luminometer (Turner
Biosystems, C A, USA) according to the instructions of
the manufacturer of the Dual-Luciferase Reporter kit
(Promega). Target-speciﬁc Renilla luciferase expression
was normalized to background Fireﬂy luciferase expres-
sion. Average expression ratios for a control plasmid were
set to 100%, and relative expression for other samples was
calculated accordingly. Two independent experiments in
triplicate were performed and the data were expressed as
the mean±SD.
Inhibition of gene targets in the full-length HIV luciferase
reporter molecular clone
Hairpin expression cassettes were assessed for eﬃcacy
against a full-length HIV-1 target by determining
knockdown in a HIV-1 molecular reporter
pNL4-3.Luc.R-E-, as has been previously described
(35,36). This molecular clone has a Fireﬂy luciferase
gene inserted into the nef gene and is capable of only a
single round of replication. Suppression of viral gene ex-
pression was measured by determining Fireﬂy luciferase
activity. HEK293 cells (120 000) were co-transfected
with 1:1 (150ng:150ng) ratio of hairpin expression
plasmid to pNL4-3.Luc.R-E-. Approximately 50ng of
phRL-CMV (Promega), which encodes Renila luciferase,
was used to control for transfection eﬃciency. Dual
luciferase reporter assays were carried out as described
above.
Northern blot analysis
Total RNA, extracted from HEK293 cells 48h after
transfection, was prepared using TriReagent
TM (Sigma)
according the manufacturer’s instructions. Thirty micro-
grams of RNA was resolved on urea denaturing 15%
polyacrylamide gels and blotted onto nylon membranes.
Decade
TM Marker (Ambion, TX, USA) was prepared ac-
cording the manufacturer’s instructions and run alongside
the cellular RNA. Blots were hybridized to DNA oligo-
nucleotides to detect products of hairpin processing. These
probes were complementary to regions spanning the target
sense or antisense sequences of the hairpins. Probes were
labelled at their 50-ends using [ -
32P] ATP with T4
Polynucleotide kinase then puriﬁed using standard pro-
cedures. Northern blot hybridization and washing were
carried out according to previously described methods
(26). After analysis using a FLA-7000 phosphorimager
(Fujiﬁlm, Japan), blots were stripped and reprobed. An
oligonucleotide probe that was complementary to U6
small nuclear RNA was used as a control to verify equal
loading of cellular RNA. Sense probe oligonucleotide se-
quences were the following: tat(S) probe: 50-GCG GAG
ACA GCG ACG AAG AGC-30, nef(S) probe: 50-GTG
CCT GGC TAG AAG CAC AAG -30, LTR(S) probe: 50-
GTA ACT AGA GAC CTC TCA GAC-30, int(S) probe:
50-GCC GGA GAG CAA TGG CTA GTC-30. Antisense
probe oligonucleotide sequences were: tat (AS) probe:
50-GCT CTT CGT CGC TGT CTC CGC-30; nef (AS)
probe: 50-CTT GTG CTT CTA GCC AGG CAC-30;
LTR (AS) probe: 50-GTC TGA GAG GTC TCT AGT
TAC-30; and int (AS) probe: 50-GAC TAG CCA TTG
CTC TCC GGC-30.
RESULTS
Optimal design of Pol III-driven single lhRNA cassettes
encoding two unique siRNA sequences
We and others have previously established that Pol
III-expressed lhRNA sequences, which include a 2–3nt
uridine 30-end overhang, can generate independent
6654 Nucleic Acids Research, 2010,Vol.38, No. 19eﬀective siRNAs in cells (19,21). However, Dicer cleavage
is initiated at the base of the hairpin duplex, and
proceeds towards the loop with decreasing cleavage eﬃ-
ciency. Previously, Liu et al. (21) have shown that
two rounds of Dicer cleavage can yield two eﬀective
siRNAs when lhRNAs are generated from a H1 Pol III
promoter. The arrangement of each siRNA along a
hairpin duplex was optimal for 44 and 45bp stems (21),
where siRNA precursors of 19bp are separated by 3–4bp.
To avoid second Dicer cleavage occurring within the ter-
minal loop, we generated lhRNAs with a longer
48–50bp complementary duplex sequence and a 9nt
loop (Figure 1A). We designed several sets of U6
lhRNA expression plasmids that each encode two
siRNA sequences. The intended siRNAs targeted
four unique HIV-1 sites within tat (29), nef (23), LTR
(20) and int (30), which have previously been shown to
be susceptible to RNAi-mediated silencing (Figure 1A
and B). In total, four diﬀerent series of lhRNAs were
generated: two sets of lhRNAs targeted against tat and
nef and two sets targeted against int and the LTR,
allowing for each siRNA-encoding sequence to be
situated in the stem base or loop side positions of the
hairpin duplex (Figure 1B). The position of these
putative 19bp+2nt siRNAs were adjusted within each
of the four lhRNA series by inserting 1, 2 or 3 symmetrical
paired mismatched bases at the junction between ﬁrst and
second siRNAs (Figure 1B). In addition, four
U6-expressing shRNA controls were generated for each
target. All lhRNAs and shRNAs included G:U pairings
that were introduced at regular intervals along the
sense strand of the duplex. The antisense sequence was
retained to ensure complete hybridization to each
intended target RNA. The addition of G:U wobbles
facilitated propagation of lhRNA expressing plasmids in
Escherichia coli (24,25).
The processing and silencing eﬃcacy of two siRNAs
derived from a single U6-driven lhRNA in cell culture
To assess the ability of variable length dual targeting
lhRNAs to inhibit their targets in cultured cells,
HEK293 cells were transfected with lhRNAs (Figure 1B)
or with individual shRNA expression plasmids. These
hairpin constructs were transiently co-transfected with a
psiCheck dual luciferase target reporter plasmid contain-
ing the tat, nef, LTR or int target sequence within the
30-UTR of the human Renilla luciferase (hRLuc) tran-
script (top panel Figure 2A and B). A lhRNA targeted
against the HBx gene of HBV (26) was used as a
negative lhRNA control. Knockdown was determined ac-
cording to the ratios of Renilla to Fireﬂy luciferase
activities and values were normalized relative to that
obtained after co-transfection with the empty U6 vector
pTZU6+1 (Mock). Regardless of the spacing at the
siRNA junctions, or the relative arrangement of the
siRNA sequence, siRNAs in the ﬁrst position of the hair-
pin (at the base of the duplex) were consistently capable of
suppressing their respective targets by  80%, which is
comparable to the knockdown achieved by individual
control shRNAs. Target inhibition from the siRNA
derived from the loopside position of the hairpin duplex
was most eﬃcient when only one mismatched base pair
was present between siRNA encoding regions (+1 conﬁg-
uration). A gradual decrease in eﬃcacy was observed with
increased spacing at the junction of the ﬁrst and second
siRNAs (Figure 2A and B).
siRNA and hairpin-intermediates derived from long
processed hairpin precursors were analysed by using
small RNA northern blot hybridization carried out on
total RNA extracted from transfected HEK293 cells.
Figure 2C and D show representative blots using four
probes complementary to each of the intended siRNA
guide strands. The signal for siRNAs derived from the
Figure 1. Design of dual targeting lhRNAs. (A) Schematic representation of an lhRNA expression cassette showing upstream U6 promoter and
the predicted structures of the transcribed lhRNAs. Dual targeting lhRNAs encode two 19bp +2nt siRNAs and have a 5bp +2nt spacer before
the loop sequence. (B) Four diﬀerent series of 48–50bp lhRNAs were generated that target tat and nef as well as int and LTR. Each 19bp
+2nt siRNA-encoding sequence is positioned either in the stem or loopside of the lhRNA duplex and separated by 1, 2 or 3 mismatched paired
bases.
Nucleic Acids Research, 2010,Vol.38, No. 19 6655Figure 2. Knockdown eﬃcacy and processing of dual targeting lhRNAs. Dual luciferase reporter assays showing knockdown of the LTR and int
targets (A) and tat and nef targets (B) when the target sequence was inserted downstream of the Renilla luciferase (hRLuc) open reading frame.
Values represented are mean ratios of Renilla to Fireﬂy luciferase (n =3, SEM) and are normalized to cells transfected with a plasmid containing a
U6 promoter only with no RNAi eﬀector sequence (mock). Small RNA (PAGE) northern blot analysis was carried out on total RNA extracted from
cells transfected with the indicated transcripts. Labelled probes complementary to the guide strand of LTR and int (C)o rtat and nef (D) were
hybridized to immobilized RNA and exposed to a phosphorimaging plate. lhRNA and shRNA precursor RNA as well as processed siRNAs are
indicated. The amount of processed guide strand is shown and normalized for each blot relative to the shRNA (set at 100). Decade Marker
TM
indicates fragment size and a probe complementary to small nuclear U6 RNA was used to detect U6 snRNA as a loading control.
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similar to that of the corresponding shRNA cassette. With
the exception of the lhtat-nef series, the guide signal of the
ﬁrst position siRNA decreased with an increase in the
mismatched paired bases inserted between the putative
siRNAs of the hairpin duplex. For example, in the case
of the LTR and int probes, very weak guide hybridization
signals were detected when three mismatched bases were
inserted between the siRNA-encoding regions. With the
exception of lhnef-tat, processed products from the
second position of the hairpin were easily detected after
transfection of plasmids encoding lhRNAs with a+1 con-
ﬁguration. The tat siRNA from the lhnef-tat set was not
detected for all spacing arrangements and correlates with
poor knockdown that was observed with tat reporter
targets (Figure 2A and B). The decrease in siRNA pro-
duction from the second position was observed in a
gradient fashion; an increase in mismatched paired bases
at the junction between siRNA encoding sequences
resulted in a decreased detection of processed second-
position guide strand. This result is in accordance with
the gradient in inhibition observed for the psiCheck
reporter gene targets (Figure 2A and B) and previously
reported for longer hairpins (19). When only one pair of
mismatched bases was inserted at the junction, siRNAs in
the second position were detected at similar levels to those
of siRNAs at the base of the stem. It should be noted that
2–3 bands, diﬀering in size by 1nt, are often visible for
single siRNA guide strands. This indicates that Dicer does
not consistently cleave the duplex at the same position and
therefore generates guide strands ranging in size from
19–22nt. While the potency of individual shRNAs diﬀer
(in the order: shtat > shnef >> shint > shLTR), reporter
gene inhibition was eﬀective for both siRNAs along the
duplex, even when transfecting with decreasing concentra-
tions of hairpin-expressing plasmid (Supplementary
Figure 1), using diﬀerent Pol III promoters (H1 and
7SK), and when combining two diﬀerent hairpin expres-
sion cassettes in a single vector (Supplementary
Figure 2A). Thus lhRNAs lhtat-nef +1 and lhLTR-int
+1 are optimally designed to allow for eﬃcient processing
along the entire hairpin duplex to produce a strong dual
siRNA response.
The generation of four independent and eﬀective siRNAs
from a single U6-driven double lhRNA (dlhRNA)
expression cassette
Placement of two shRNAs together within the same tran-
script has been shown to produce siRNAs targeted to two
independent sites (37,38). Although Pol III-expressed
shRNAs and lhRNAs consist of deﬁned 50- and
30-termini that facilitate Dicer recognition and cleavage,
shRNAs expressed from Pol II promoters produce longer
50-leader and 30-trailer sequences which often results in
variable production of active siRNAs (39–41). To
develop a system for generating four separate siRNAs
from a single transcript, we combined the two most eﬀect-
ive lhRNAs described here. lhtat-nef+1 and lhLTR-int+1
were placed in tandem to generate two dlhRNA expres-
sion constructs (Figure 3A). A 2-nt UU bridge was
included between each lhRNA to mimic the 30-overhang
generated for a single Pol III-generated lhRNA. dlhLI-TN
and dlhTN-LI included lhRNAs lhLTR-int +1 and
lhtat-nef +1 in either the 50-position or 30-position of the
dlhRNA transcripts, respectively (Figure 3B).
To characterize the processing of dlhRNAs, small RNA
northern blot analysis was performed as before. Figure 3C
shows the signals obtained following hybridization with
antisense (AS) and sense (S) probes to detect siRNA
guide and passenger strands. All probes detected the
full-length dlhRNA transcripts from both dlhRNA con-
structs. However, only dlhLI-TN generated detectable
processed precursors representing both lhRNAs. For
dlhTN-LI, strong signals were detected for the
50-position lhRNA precursor, lhtat-nef +1, with S and
AS probes to tat and nef. No hybridization signal was
detected by either S or AS probes to LTR and int for
the 30-position lhLTR-int +1, suggesting that this
lhRNA precursor is rapidly degraded following initial
Dicer cleavage of the dlhRNA transcript. For dlhLI-TN,
the 50-position lhRNA, lhLTR-int +1, was detected by
S and AS probes targeted to LTR and int. The lhRNA
in the 30-position (lhtat-nef+1) was detected by S and AS
tat and nef probes, but at a lower concentration than that
of the 50-position lhRNA precursor. Again this suggests
that processing of the dlhRNA renders lhRNA at the
30-position less stable. Nevertheless, all four siRNAs
guide sequences were detected from dlhLI-TN
demonstrating that a single dlhRNA construct is capable
of successfully generating four independent siRNA guide
strands.
To determine whether the guide strands were capable of
eﬀecting knockdown of deﬁned HIV targets, a
dual-luciferase reporter gene assay was performed as
before. Double long hairpin RNA dlhLI-TN inhibited
all four targets by 70–80% (Figure 3D), indicating that
four eﬀective siRNAs were generated from this dlhRNA
and that a decreased amount of tat and nef guide strand
derived from the second lhRNA did not aﬀect knockdown
under these conditions of transient transfection. As
expected, dlhTN-LI, only inhibited tat and nef reporter
targets, conﬁrming that compromised processing of the
second position lhRNA aﬀects downstream guide strand
production and subsequent target knockdown. To deter-
mine whether the passenger strand of each putative pro-
cessed siRNA was active, dual-luciferase reporter
constructs were generated that included AS targets. The
passenger strands were largely ineﬀective, and guide
strand formation was according to the intended bias.
Ability of the dlhRNAs to inhibit cognate targets within
the context of a full-length HIV-1 sequence was also
determined (Figure 4A and B). To quantify the anti-viral
eﬀects of these hairpins, we co-transfected the shRNA-,
lhRNA- and dlhRNA-expressing plasmids with the HIV-1
molecular clone pNL4-3.Luc.E-R-. This reporter plasmid
lacks functional env and the nef reading frame is
substituted with a Fireﬂy luciferase ORF (Figure 4A).
Knockdown was measured by determining Fireﬂy
luciferase activity, which was normalized to activity of
Renilla luciferase that was consitutively expressed from a
co-transfected plasmid. Luciferase ratios were determined
Nucleic Acids Research, 2010,Vol.38, No. 19 6657Figure 3. Generation of four eﬀective individual siRNAs from a single dlhRNA transcript containing two adjacent lhRNAs. (A) Schematic repre-
sentation of a dlhRNA expression cassette driven by a single promoter showing the predicted structure and derivation of four siRNAs. (B) Eﬀective
dual targeting long hairpin RNAs lhtat-nef+1 and lhLTR-int+1 were both combined in 50 or 30 positions within the dlhRNA transcript to generate
lhLI-TN and lhTN-LI.( C) Low molecular weight northern blot analysis was carried out on total RNA extracted from cells transfected with the
dlhRNA expression cassettes with individual targeting shRNAs used as positive controls. Labelled probes complementary to the guide and antisense
strand of LTR, int, tat and nef were hybridized to immobilized RNA and exposed to a phosphorimaging plate. Precursor hairpin RNAs as well as
processed siRNAs are indicated. The amount of processed guide strand is shown and normalized for each blot relative to the shRNA (set at 100).
Decade Marker
TM indicates fragment size and a probe complementary to small nuclear U6 RNA was used to detect U6 snRNA as a loading control.
(D) Dual luciferase reporter assays showing knockdown of the sense (S) and antisense (AS) targets of LTR, int, tat and nef when the target sequence
was inserted downstream of the Renilla luciferase open reading frame. Values represented are mean ratios of Renilla to Fireﬂy luciferase
(n=3,±SEM) and are normalized to cells transfected with a plasmid containing a U6 promoter only with no RNAi eﬀector sequence (mock).
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individual shRNAs targeted to the tat and nef sequences
showed potent luciferase inhibition (>80%), whilst
shRNAs targeted to LTR and int were less eﬀective
(70% and 40% knockdown, respectively). This may
reﬂect a lower potency of individual LTR and int
siRNAs (Supplementary Figure 1). As expected, inhibition
of the HIV-1 reporter by lhRNAtat-nef was similar to that
achieved by each of the tat or nef shRNAs. However, the
dual targeting hairpin lhLTR-int was only capable of in-
hibiting the HIV-1 reporter by  20%. This conﬁrms
previous observations that LTR and int targets were
silenced less eﬀectively when produced from lhLTR-int.
Importantly, both double lhRNA expression cassettes
achieved good silencing of the reporter gene. However,
dlhTN-LI achieved slightly better silencing than
dlhLI-TN. This may be a result of better knockdown
achieved by the more eﬃciently processed nef- and tat-
targeting guides (Figure 3C). Collectively these data
indicate that although there may be variability in the
silencing eﬃcacy of individual siRNAs, compensatory
eﬀects may result in good overall silencing which is a de-
sirable property of coRNAi applications.
lhRNA cassettes do not disrupt independent
RNAi-mediated gene silencing or stimulate
the innate IFN response
An important safety concern of potentially therapeutic
lhRNAs is the possible disruptive eﬀect that they may
have on the endogenous cellular miRNA pathway. Both
exogenous siRNAs and shRNAs can compete with each
other or with endogenous miRNAs for access to compo-
nents of the RNAi machinery (42,43). However, RNAi
activators that are present in lower concentrations, are
less likely to saturate the RNAi pathway (34,43,44). To
assess eﬀects of lhRNA cassettes on independent RNAi,
two assays were performed to determine whether lhRNA
expression cassettes have any derepression eﬀect on
silencing caused by an endogenous or an exogenous
miRNA. In the ﬁrst assay, HEK293 cells were
co-transfected in a 1:1 ratio with an exogenous miRNA
shuttle, pCMV miR-31 HBx (targeted to a unique site
within the HBV genome), and its cognate dual-luciferase
reporter target plasmid, psiCheck HBx (34). Diminishing
amounts of plasmids expressing shRNA, lhRNA or
dlhRNAs relative to pCMV miR-31 HBx were
co-transfected in ratios of 5:1, 1:1 and 0.1:1, respectively.
U6 promoter-driven shLTR showed signiﬁcant derepres-
sion of miR-31 HBx mediated knockdown at ratios of 5:1
and 1:1 but not at a ratio of 0.1:1. However, equivalent
ratios of U6 promoter-driven lhLTR-int or dlhLI-TN had
no eﬀect on miR-31 HBx knockdown eﬃcacy (Figure 5A).
In the second assay, Huh-7 cells were co-transfected with a
panel of hairpin-expressing plasmids together with a
dual-luciferase reporter plasmid containing seven copies
of a natural miR-16 target site (18). A miRNA ‘sponge’
construct expressing seven copies of an imperfectly
matched miR-16 target, pU6 miR16Tx7, signiﬁcantly
derepressed miR-16 silencing of its reporter cognate
(Figure 5B). However, at a concentration of 5:1 (sh/
lhRNA expression cassette:target reporter plasmid),
none of the hairpin RNAs had any detectable disruptive
eﬀect on endogenous miR-16 silencing of its reporter
cognate. Together, these results suggest that lhRNAs
and dlhRNAs, although expressed from a potent U6
promoter, are less likely than shRNAs to compete with
RNAi pathway components necessary for either exogen-
ous or endogenous miRNA function. Although lhRNA
and shRNA expression cassettes are expressed from U6
Pol III promoters, intracellular precursors and siRNA
guide strands from lhRNA cassettes are present at lower
concentrations than those derived from shRNA expres-
sion cassettes (Figure 3C). Lastly, to exclude the possibil-
ity of non-speciﬁc eﬀects caused by the induction of an
interferon response, IFN-  mRNA concentrations were
measured in transfected cells. As previously shown for
other Pol-III generated lhRNAs (21,22,26), quantitative
qRT–PCR demonstrated that none of the hairpin cas-
settes induced expression of IFN-  (Figure 5C).
DISCUSSION
Despite extensive optimization of hairpin stem length,
siRNA sequence, and the spatial arrangement of unique
siRNAs along a lhRNA duplex, it seemed unlikely that
expressed lhRNAs can be designed to produce more than
two, possibly three, separate eﬀective siRNAs (19,21,27).
Deriving high concentrations of more than two independ-
ent functional siRNAs from an lhRNA scaﬀold remains
Figure 4. Inhibition of full-length HIV-1 molecular clone
pNL4-3.Luc.R-E-. (A) The separate regions of the NL4-3.Luc
sequence targeted by the four generated siRNAs are shown schematic-
ally. (B) HEK293 cells were transfected in a 1:1 ratio of
pNL4-3.Luc.R-E- together with indicated hairpin constructs and trace
amounts of Renilla luciferase plasmid phRL-CMV. The four
siRNA-targeted regions are indicated above in the modiﬁed HIV
genome of pNL4-3.Luc.R-E-. Values represented are mean ratios of
Fireﬂy luciferase normalized to Renilla luciferase (n=3,±SEM) and
expressed as a percentage of mock (pU6+1) transfected cells (set at
100%).
Nucleic Acids Research, 2010,Vol.38, No. 19 6659diﬃcult and requires new ways of exploiting the process-
ing of dsRNA substrates by Dicer. To develop eﬀective
Pol III-driven lhRNAs expressing two functional siRNAs,
we tested the eﬀects of combining two 19bp+2nt siRNAs
within a single 48–50bp lhRNA duplex, and included up
to three mismatched paired bases between each
siRNA-encoding sequence. Liu et al. (21) showed that a
single mismatched paired base between two eﬀective
siRNAs at the centre of the lhRNA stem is well tolerated
and results in the same level of processing or siRNA
activity within the context of a 43bp lhRNA. In total,
we established a panel of four unique anti-HIV siRNAs
was used to generate 12 dual-targeting lhRNA structures.
When tested against respective HIV targets, we observed
an inverse correlation between siRNA silencing potency
and increased spacing between each siRNA along the
duplex. Optimal siRNA processing from lhRNAs
occurred when only one mismatched paired base was
placed between each 19bp + 2nt siRNA, and this was
irrespective of siRNA position or sequence. These data
are in accordance with previously published data report-
ing on dual-targeting lhRNAs (21), and is in accordance
with predicted Dicer cleavage intervals of  22nt (20bp
+2nt) in human cells (45). With some dual-acting
lhRNAs, processing of the siRNA at the ﬁrst position di-
minished when more mismatches were inserted in the
lhRNA duplex at the junction of each the siRNAs. This
is likely to be caused by an inhibitory eﬀect on processing
which is caused by bulges occurring at the Dicer cleavage
sites (46). However, the +1 conﬁguration did not aﬀect
Dicer processing through the lhRNA duplex.
Importantly, we were able to identify two eﬀective and
optimized dual-targeting anti-HIV lhRNAs, lhtat-nef +1
and lhLTR-int+1, which together produce high levels of
four siRNAs that inhibit their cognate targets. These
lhRNAs were ideally optimized for inclusion into a
single combinatorial dlhRNA expression cassette.
Based on HIV reverse-transcriptase error rates, it has
been determined that a minimum of four separate HIV
target sites should be targeted simultaneously to prevent
the emergence of RNAi-resistant viral species (47,48).
Therefore, it was encouraging that the dlhRNA design,
with two highly eﬀective lhRNAs joined together within
a single expressed transcript, enabled accurate processing
into four active anti-HIV siRNAs. Apart from
polycistronic miRNA mimics (13–17), this is the ﬁrst
example of four active guide strands being derived from
a single Pol III expression cassette, and provides a useful
framework for generating eﬀective coRNAi strategies
against highly evolving viruses or multiple rogue genetic
elements. Nevertheless, the mechanism by which these
dlhRNA structures are processed is unclear. Although
previous attempts to generate binary or dual shRNA-
containing transcripts suggest that these duplexes can be
processed into siRNA-sized products, the mechanism for
their intracellular cleavage remains unexplained (37,38).
Although we do not exclude involvement of other
RNases in the processing of dlhRNA precursors,
Figure 5. Assessment of non-speciﬁc eﬀects mediated by long hairpin RNAs. (A) Analysis of eﬀects of a shRNA, lhRNA and dlhRNA expression
cassette on the repression of HBx target reporter sequence by an exogenously introduced miR-31 HBx shuttle using a dual luciferase assay.
Co-transfection of reporter plasmid, containing an HBx target sequence downstream of the Renilla luciferase ORF, was carried out together with
three diﬀerent concentrations of RNAi expression cassettes and empty backbone plasmid (mock). Mean ratios of Renilla to Fireﬂy luciferase (as a
percentage of psiCheck2 empty backbone vector) were used to determine derepression of miR-31 HBx. Statistical signiﬁcance was determined using a
one-way ANOVA relative to mock transfected control (pU6 +1, *P<0.05 and **P <0.001). (B) The eﬀect of hairpin expression cassettes on the
function of endogenous miR-16 was analysed following co-transfection of a dual luciferase reporter plasmid containing seven copies of the miR-16
target downstream of the hRluc ORF together with the indicated hairpin-expressing plasmids or miR-16 sponge plasmid expressing seven copies of
an imperfectly matched miR-16 target. Mean ratios of Renilla to Fireﬂy luciferase were used to determine derepression of miR-16. (C) The induction
of the IFN response was assessed by measuring IFN-  mRNA concentration in total RNA extracted from cells transfected with the indicated
shRNA, lhRNA and multi-lhRNA expression cassettes. Poly I:C served as a positive control. Mean normalized ratios of IFN- :GAPDH
(n=3,±SEM) determined by using quantitative RT–PCR are indicated. Statistical signiﬁcance was determined using a one-way ANOVA
relative to mock transfected control (pU6 +1, *P<0.001).
6660 Nucleic Acids Research, 2010,Vol.38, No. 19it seems likely that Dicer is responsible for the initial
cleavage to form lhRNA species. This is supported by
evidence that Dicer is capable of cleaving hairpins with
either 50- and 30-extensions, albeit less eﬃciently (39–41).
The fact that the 30-position lhRNA is present in reduced
amounts (or degraded completely) suggests that, once
cleaved, the 50-position lhRNAs is initially protected by
Dicer before being processed into shorter hairpin
products. Since the intrinsic stability of the two lhRNAs
is the same within the dlhRNA system, it remains odd that
the 30-position lhRNA in dlhLI-TN is processed but
is degraded in the context of dlhTN-LI. The only
diﬀerence appears to be the sequence presented for
second round Dicer cleavage. Moreover, the 50-terminus
of the lhLTR-int within dlhLI-TN has a triphosphate
moiety generated by Pol III transcription, a feature
which is lacking for lhLTR-int in the context of
dlhTN-LI, and which may add to the stability of
lhLTR-int. However a clearer picture is likely to emerge
with the study of more dlhRNA combinations comprising
diﬀerent lhRNAs.
Although coRNAi aims to induce strong silencing from
multiple guide strands, high levels of shRNA produced
from Pol III promoters are known to be associated with
unwanted cellular toxicities. High levels of expressed
shRNAs in the liver may cause fatality in mice as a
result of saturation of the endogenous RNAi machinery
(10). In addition, McBride and colleagues have observed
toxicities caused by shRNA-based vectors in brain, which
may have been caused by a buildup of guide strand RNA
(49,50). Replacement of shRNAs with miRNA shuttles
reduced neurotoxicities, suggesting that natural RNAi
pathway precursors are less likely to interfere with en-
dogenous miRNA functions. Although not fully under-
stood, it is likely that highly expressed shRNAs abrogate
the function of natural and exogenous miRNAs
(10,34,43,44,51,52). Here, we have shown that both
lhRNAs and dlhRNAs do not induce the same disruptive
eﬀects on endogenous miRNA that were observed after
transfection of a U6-generated shRNA. This augurs well
for the safety and potential therapeutic application of
these constructs. Moreover, although there have been
concerns about induction of the IFN response by
long (>30bp) duplex RNA, we did not detect any
IFN-b mRNA activation for any of the hairpins tested.
This conﬁrms previously reported results from analysis of
expressed lhRNAs (24,25,53), and suggests that intracel-
lular transcription of dsRNA hairpins is less likely than
exogenous synthetic RNA to activate the type 1 IFN
response. This is explained by the fact that expressed
lhRNAs, unlike transfected synthetic duplex RNA, do
not traverse the endosome which contain Toll-like recep-
tors that are typically activated by introduced siRNAs
(54,55).
In conclusion, we show that RNA Pol III-expressed
dlhRNA transcripts may be processed to generate four
independent siRNAs that can eﬀect signiﬁcant
knockdown of non-contiguous siRNA-susceptible
regions of HIV-1. Although there is some variation in
the processing eﬃciency of the 30-lhRNA, eﬀective
coRNAi can be achieved. Importantly, the dlhRNA
constructs described here do not appear to disrupt the
natural miRNA pathway, which represents an important
objective for their implementation as potential therapeutic
agents. This design of dlhRNA cassettes improves on the
limited versatility of expressed lhRNAs and provides a
useful approach for generating transcripts with modular
lhRNAs motifs that achieve eﬀective coRNAi in mamma-
lian cells.
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